vs
AdvanSix Inc.（ASIX）与OSI SYSTEMS INC（OSIS）财务数据对比。点击上方公司名可切换其他公司
OSI SYSTEMS INC的季度营收约是AdvanSix Inc.的1.3倍（$464.1M vs $359.9M），OSI SYSTEMS INC净利率更高（8.3% vs -0.8%，领先9.1%），OSI SYSTEMS INC同比增速更快（10.5% vs 9.4%），OSI SYSTEMS INC自由现金流更多（$55.5M vs $36.1M），过去两年OSI SYSTEMS INC的营收复合增速更高（7.0% vs 3.4%）
AdvanSix Inc.是一家美国化工企业，主营尼龙6以及己内酰胺、硫酸铵肥料等相关化工产品。该公司原为霍尼韦尔旗下树脂与化工事业部，于2016年分拆独立，2019年预估营收达14亿美元，其企业历史可追溯至1884年在宾夕法尼亚州法兰克福成立的H. W. Jayne公司。
OSI系统公司是总部位于美国加利福尼亚州的企业，主营安全检测系统、医疗设备及光电器件三大业务板块，产品涵盖机场安检X光机、金属探测器、医疗监护与麻醉系统等，旗下拥有Spacelabs Healthcare、Rapiscan Systems、OSI Optoelectronics等子公司，全球员工规模约3180人。
ASIX vs OSIS — 直观对比
营收规模更大
OSIS
是对方的1.3倍
$359.9M
营收增速更快
OSIS
高出1.2%
9.4%
净利率更高
OSIS
高出9.1%
-0.8%
自由现金流更多
OSIS
多$19.4M
$36.1M
两年增速更快
OSIS
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $359.9M | $464.1M |
| 净利润 | $-2.8M | $38.7M |
| 毛利率 | 7.6% | 32.7% |
| 营业利润率 | -0.7% | 12.7% |
| 净利率 | -0.8% | 8.3% |
| 营收同比 | 9.4% | 10.5% |
| 净利润同比 | -892.9% | 2.3% |
| 每股收益（稀释后） | $-0.11 | $2.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASIXOSIS
| Q4 25 | $359.9M | $464.1M | ||
| Q3 25 | $374.5M | $384.6M | ||
| Q2 25 | $410.0M | $505.0M | ||
| Q1 25 | $377.8M | $444.4M | ||
| Q4 24 | $329.1M | $419.8M | ||
| Q3 24 | $398.2M | $344.0M | ||
| Q2 24 | $453.5M | $480.9M | ||
| Q1 24 | $336.8M | $405.4M |
净利润ASIXOSIS
| Q4 25 | $-2.8M | $38.7M | ||
| Q3 25 | $-2.6M | $20.6M | ||
| Q2 25 | $31.4M | $52.7M | ||
| Q1 25 | $23.3M | $41.1M | ||
| Q4 24 | $352.0K | $37.8M | ||
| Q3 24 | $22.3M | $17.9M | ||
| Q2 24 | $38.9M | $44.7M | ||
| Q1 24 | $-17.4M | $34.0M |
毛利率ASIXOSIS
| Q4 25 | 7.6% | 32.7% | ||
| Q3 25 | 6.8% | 32.0% | ||
| Q2 25 | 14.3% | 33.3% | ||
| Q1 25 | 14.2% | 33.8% | ||
| Q4 24 | 3.4% | 35.1% | ||
| Q3 24 | 14.4% | 35.3% | ||
| Q2 24 | 17.9% | 32.1% | ||
| Q1 24 | 0.9% | 33.6% |
营业利润率ASIXOSIS
| Q4 25 | -0.7% | 12.7% | ||
| Q3 25 | -0.9% | 8.6% | ||
| Q2 25 | 7.7% | 14.5% | ||
| Q1 25 | 7.7% | 12.7% | ||
| Q4 24 | -3.9% | 13.8% | ||
| Q3 24 | 7.5% | 8.8% | ||
| Q2 24 | 11.5% | 13.1% | ||
| Q1 24 | -7.0% | 12.7% |
净利率ASIXOSIS
| Q4 25 | -0.8% | 8.3% | ||
| Q3 25 | -0.7% | 5.3% | ||
| Q2 25 | 7.7% | 10.4% | ||
| Q1 25 | 6.2% | 9.3% | ||
| Q4 24 | 0.1% | 9.0% | ||
| Q3 24 | 5.6% | 5.2% | ||
| Q2 24 | 8.6% | 9.3% | ||
| Q1 24 | -5.2% | 8.4% |
每股收益（稀释后）ASIXOSIS
| Q4 25 | $-0.11 | $2.22 | ||
| Q3 25 | $-0.10 | $1.18 | ||
| Q2 25 | $1.15 | $3.04 | ||
| Q1 25 | $0.86 | $2.40 | ||
| Q4 24 | $0.02 | $2.22 | ||
| Q3 24 | $0.82 | $1.05 | ||
| Q2 24 | $1.43 | $2.57 | ||
| Q1 24 | $-0.65 | $1.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $19.8M | $336.7M |
| 总债务越低越好 | — | $1.0B |
| 股东权益账面价值 | $815.2M | $845.5M |
| 总资产 | $1.7B | $2.5B |
| 负债/权益比越低杠杆越低 | — | 1.19× |
8季度趋势，按日历期对齐
现金及短期投资ASIXOSIS
| Q4 25 | $19.8M | $336.7M | ||
| Q3 25 | $23.7M | $124.4M | ||
| Q2 25 | $18.4M | $106.4M | ||
| Q1 25 | $8.3M | $95.8M | ||
| Q4 24 | $19.6M | $101.6M | ||
| Q3 24 | $17.3M | $85.1M | ||
| Q2 24 | $12.1M | $95.4M | ||
| Q1 24 | $20.6M | $101.4M |
总债务ASIXOSIS
| Q4 25 | — | $1.0B | ||
| Q3 25 | — | $442.2M | ||
| Q2 25 | — | $471.6M | ||
| Q1 25 | — | $473.2M | ||
| Q4 24 | — | $474.8M | ||
| Q3 24 | — | $476.3M | ||
| Q2 24 | — | $137.6M | ||
| Q1 24 | — | — |
股东权益ASIXOSIS
| Q4 25 | $815.2M | $845.5M | ||
| Q3 25 | $818.2M | $946.0M | ||
| Q2 25 | $823.7M | $951.1M | ||
| Q1 25 | $794.4M | $879.3M | ||
| Q4 24 | $774.6M | $825.8M | ||
| Q3 24 | $766.4M | $786.5M | ||
| Q2 24 | $746.6M | $863.5M | ||
| Q1 24 | $713.2M | $813.4M |
总资产ASIXOSIS
| Q4 25 | $1.7B | $2.5B | ||
| Q3 25 | $1.7B | $2.3B | ||
| Q2 25 | $1.6B | $2.2B | ||
| Q1 25 | $1.6B | $2.1B | ||
| Q4 24 | $1.6B | $2.1B | ||
| Q3 24 | $1.5B | $2.1B | ||
| Q2 24 | $1.5B | $1.9B | ||
| Q1 24 | $1.5B | $1.8B |
负债/权益比ASIXOSIS
| Q4 25 | — | 1.19× | ||
| Q3 25 | — | 0.47× | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | 0.54× | ||
| Q4 24 | — | 0.57× | ||
| Q3 24 | — | 0.61× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $63.7M | $62.2M |
| 自由现金流经营现金流 - 资本支出 | $36.1M | $55.5M |
| 自由现金流率自由现金流/营收 | 10.0% | 12.0% |
| 资本支出强度资本支出/营收 | 7.7% | 1.4% |
| 现金转化率经营现金流/净利润 | — | 1.61× |
| 过去12个月自由现金流最近4个季度 | $6.4M | $137.2M |
8季度趋势，按日历期对齐
经营现金流ASIXOSIS
| Q4 25 | $63.7M | $62.2M | ||
| Q3 25 | $26.6M | $17.1M | ||
| Q2 25 | $21.1M | $562.0K | ||
| Q1 25 | $11.4M | $81.6M | ||
| Q4 24 | $64.2M | $52.5M | ||
| Q3 24 | $57.3M | $-37.2M | ||
| Q2 24 | $50.2M | $-29.0M | ||
| Q1 24 | $-36.2M | $-52.1M |
自由现金流ASIXOSIS
| Q4 25 | $36.1M | $55.5M | ||
| Q3 25 | $66.0K | $10.1M | ||
| Q2 25 | $-7.2M | $-5.6M | ||
| Q1 25 | $-22.6M | $77.1M | ||
| Q4 24 | $29.8M | $47.1M | ||
| Q3 24 | $26.8M | $-44.9M | ||
| Q2 24 | $16.7M | $-37.5M | ||
| Q1 24 | $-71.6M | $-57.0M |
自由现金流率ASIXOSIS
| Q4 25 | 10.0% | 12.0% | ||
| Q3 25 | 0.0% | 2.6% | ||
| Q2 25 | -1.7% | -1.1% | ||
| Q1 25 | -6.0% | 17.4% | ||
| Q4 24 | 9.1% | 11.2% | ||
| Q3 24 | 6.7% | -13.0% | ||
| Q2 24 | 3.7% | -7.8% | ||
| Q1 24 | -21.3% | -14.1% |
资本支出强度ASIXOSIS
| Q4 25 | 7.7% | 1.4% | ||
| Q3 25 | 7.1% | 1.8% | ||
| Q2 25 | 6.9% | 1.2% | ||
| Q1 25 | 9.0% | 1.0% | ||
| Q4 24 | 10.4% | 1.3% | ||
| Q3 24 | 7.7% | 2.2% | ||
| Q2 24 | 7.4% | 1.8% | ||
| Q1 24 | 10.5% | 1.2% |
现金转化率ASIXOSIS
| Q4 25 | — | 1.61× | ||
| Q3 25 | — | 0.83× | ||
| Q2 25 | 0.67× | 0.01× | ||
| Q1 25 | 0.49× | 1.98× | ||
| Q4 24 | 182.29× | 1.39× | ||
| Q3 24 | 2.57× | -2.07× | ||
| Q2 24 | 1.29× | -0.65× | ||
| Q1 24 | — | -1.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
OSIS
| Security Division | $334.7M | 72% |
| Optoelectronics And Manufacturing Division | $92.8M | 20% |
| Healthcare Division | $36.5M | 8% |
